Primary Job Title COO Primary Organization RetroSense Therapeutics
Gender Male
Thomas Rea brings over 25 years of scientific and management experience in research and development to his role with RetroSense Therapeutics. His pharmaceutical domain experience has ranged from big pharma (Upjohn, Parke-Davis/Warner Lambert, Pfizer) to startups in both North America and Europe with projects involving low molecular weight
compounds or biotechnology-based pharmaceuticals. He was one of four co-founders of Esperion Therapeutics (Ann Arbor) in 1998.
Mr. Rea has contributed to drug discovery and development in a number of clinically relevant areas including viral disease, oncology, epithelial cell and plasma hyperlipidemia drug programs that led to specific new therapeutic entities such as pseudorabies virus vaccine, Rogaine (minoxidil), Lipitor (atorvastatin), synthetic high density lipoproteins and related lipid and peptide formulations. He has managed biopharmaceutical projects domestically and overseas. His primary management roles for these projects were in the areas of biopharmaceutical development with international manufacturing suppliers and contract research organizations, GMP production of clinical trial materials, and regulatory agency compliance. He has completed corporate development work in the areas of risk analysis, licensing evaluations, and strategic planning. He has a broad publication, scientific and business presentation record.
Mr. Rea received BS and MS degrees in Microbiology from Ohio State University.
